Arie Perry

Arie Perry is a Professor at the University of California San Francisco (UCSF) specializing in surgical neuropathology, with a focus on central nervous system (CNS) tumors. Their translational research aims to develop novel diagnostic and prognostic markers for brain tumors using immunohistochemical, molecular cytogenetic, and genomic screening techniques.

• Clinical Expertise: CNS tumors, gliomas, meningiomas, pediatric malignancies
• Education: B.S. in Zoology (University of Texas at Austin, 1986), M.D. (UT Southwestern Medical Center, 1990), Anatomic/Pathology Residency (UT Southwestern, 1994), Neuropathology Fellowship (Mayo Clinic, 1998)
• Collaborations: Multi-institutional research teams across the U.S. and abroad

Their research interests center on molecular markers for tumorigenesis, grading schemes, and improving patient management through targeted therapies. Recent work includes genomic profiling of meningiomas, molecular drivers of glioma evolution, and novel CNS tumor classifications. Their publications reflect expertise in tumor heterogeneity, synaptic connectivity, and therapeutic resistance.

Scientific awards include multiple Distinguished Service Teaching Awards (WUSM, 2001–2013), Professor of the Year Awards (2007, 2010), and recognition in Best Doctors in America and America’s Top Doctors for Cancer. They maintain an active private consultation service for complex neuropathology cases globally.